LAKE ZURICH, Ill., May 27 /PRNewswire/ -- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that on Friday, May 29, 2010, the American Society for Apheresis (ASFA) will present Fenwal biomedical engineer Katherine Radwanski with the prestigious Junior Investigator Award for her research on photopheresis.
Photopheresis is a medical therapy where blood is collected from patients and treated with photo-sensitive drugs. The drugs are then activated outside the body by exposing the blood to ultraviolet light before returning the blood to the patients.
Radwanski's research demonstrates early feasibility for photopheresis methods used in Europe, but not yet approved for use in the United States. Her work is being used to develop photopheresis as a therapeutic protocol for Fenwal's Amicus® system, a machine used to collect platelets, mononuclear cells, and other blood components. Fenwal is working to expand the clinical uses for its automated-collection technologies, including new therapeutic plasma exchange methods.
Radwanski will present her award-winning abstract, "The Effects of Cell Concentration, UV Dose and 8-Methoxypsoralen Concentration on Human Lymphocyte Apoptosis Post Photopheresis," on Thursday, May 27, 2010 in a plenary abstract session during the 2010 ASFA Annual Meeting in New Orleans.
The ASFA Junior Investigator Award is given to the primary author of an outstanding abstract submitted by an ASFA member who has worked in the transfusion field for less t
|SOURCE Fenwal, Inc.|
Copyright©2010 PR Newswire.
All rights reserved